Home

Indo Us Bio-tech Ltd EPS

Image

Indo US Bio-Tech Ltd

NSE: INDOUS

EPS

₹ 8.37

Last updated on: Mar 13, 2025

Key Highlights

  • The Earning per Share of Indo US Bio-Tech Ltd is ₹ 8.37 as of 13 Mar 25 .
  • The earning per share of Indo US Bio-Tech Ltd changed from ₹ 2.37 to ₹ 2.52 over 7 quarters. This represents a CAGR of 3.57% .

Historical Earning per Share of Indo US Bio-Tech Ltd

No data available

* All values are in

Company Fundamentals for Indo US Bio-Tech Ltd

Market Cap

328 Cr

EPS

8.4

P/E Ratio (TTM)

19.6

P/B Ratio (TTM)

4.7

Day’s High

174.4

Day’s Low

163.95

DTE

0.2

ROE

22.0

52 Week High

386.0

52 Week Low

163.95

ROCE

20.5

Market Price of Indo US Bio-Tech Ltd

1M

1Y

3Y

5Y

Monitoring Indo US Bio-Tech Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
13 Mar 2025163.95
12 Mar 2025167.85
11 Mar 2025175
10 Mar 2025183
07 Mar 2025188.95
06 Mar 2025193
05 Mar 2025185.4
04 Mar 2025194.5
03 Mar 2025192.55
28 Feb 2025196.9

SWOT Analysis Of Indo US Bio-Tech Ltd

Strength

2

che

Weakness

1

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Indo US Bio-Tech Ltd

Asset Value vs Market Value of Indo US Bio-Tech Ltd

Market Value

329

Asset Value

Value addition

5.9 X

47

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Indo US Bio-Tech Ltd328.75
Hindustan Unilever Ltd511236
Nestle India Ltd211329
Varun Beverages Ltd164996
Britannia Industries Ltd113884
Godrej Consumer Products Ltd104741

Historical Market Cap of Indo US Bio-Tech Ltd

No data available

* All values are in crore

Historical Revenue of Indo US Bio-Tech Ltd

No data available

* All values are in crore

Historical EBITDA of Indo US Bio-Tech Ltd

No data available

* All values are in crore

Historical Net Profit of Indo US Bio-Tech Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Indo US Bio-Tech Ltd News Hub

Indo US Bio-Tech standalone net profit rises 33.76% in the June 2024 quarter

Net profit of Indo US Bio-Tech rose 33.76% to Rs 3.17 crore in the quarter ended June 2024 as agains

Read more

09 Aug 24

Indo US Bio-Tech to announce Quarterly Result

Indo US Bio-Tech will hold a meeting of the Board of Directors of the Company on 8 August 2024. Powe

Read more

02 Aug 24

Indo US Bio-Tech to conduct AGM

Indo US Bio-Tech announced that the Annual General Meeting (AGM) of the company will be held on 30 S

Read more

18 Sept 24

Indo US Bio-Tech announces board meeting date

Indo US Bio-Tech will hold a meeting of the Board of Directors of the Company on 14 November 2024 Po

Read more

07 Nov 24

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Indo US Bio-Tech Ltd

What is the EPS of Indo US Bio-Tech Ltd stock?

The Earnings Per Share (EPS) of Indo US Bio-Tech Ltd is 8.37. An EPS is the amount of net income attributed to each share of a common stock.

How is Indo US Bio-Tech Ltd EPS calculated?

The EPS of Indo US Bio-Tech Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Indo US Bio-Tech Ltd report its EPS?

Indo US Bio-Tech Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Indo US Bio-Tech Ltd EPS?

Factors that influence the EPS of Indo US Bio-Tech Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Indo US Bio-Tech Ltd EPS growth indicate future performance?

Yes, consistent growth in Indo US Bio-Tech Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions